IN8BIO, Inc.
INAB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001740279
No open-market purchases or sales by IN8BIO, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $5.35M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in IN8BIO, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +3 vs. Q3 2025
- Shares held
- 3.23M
- +2.25M (+229.3%) vs. Q3 2025
- Total value
- $7.45M
- +$5.32M (+250.3%) vs. Q3 2025
- New holders
- 7
- 7 more added
- Sold out
- 4
- 6 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INAB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $5.35M |
| Q1 2026 | 19 | $5.55M |
| Q4 2025 | 22 | $7.45M |
| Q3 2025 | 19 | $2.13M |
| Q2 2025 | 12 | $1.83M |
| Q1 2025 | 28 | $3.60M |
| Q4 2024 | 26 | $7.72M |
| Q3 2024 | 26 | $2.06M |
| Q2 2024 | 26 | $6.77M |
| Q1 2024 | 32 | $10.2M |
| Q4 2023 | 30 | $11.4M |
| Q3 2023 | 21 | $2.58M |
| Q2 2023 | 22 | $3.59M |
| Q1 2023 | 17 | $1.78M |
| Q4 2022 | 16 | $2.79M |
| Q3 2022 | 17 | $2.42M |
| Q2 2022 | 15 | $5.50M |
| Q1 2022 | 14 | $7.02M |
| Q4 2021 | 14 | $7.80M |
| Q3 2021 | 13 | $12.2M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding IN8BIO, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Alyeska Investment Group, L.P. | 957,484 | $2.23M | 0.01% | +875,000+1,060.8% | Added |
| Franklin Resources Inc | 914,531 | $2.05M | 0.00% | +724,637+381.6% | Added |
| 683 Capital Management, LLC | 724,637 | $1.70M | 0.14% | +724,637 | New |
| BIOS Capital Management, LP | 253,417 | $593.0K | 0.72% | −33,247−11.6% | Reduced |
| Stonepine Capital Management, LLC | 164,893 | $385.9K | 0.31% | +5,472+3.4% | Added |
| Two Sigma Advisers, LP | 36,351 | $85.1K | 0.00% | −9,400−20.5% | Reduced |
| Vanguard Group Inc | 28,348 | $66.3K | 0.00% | −31,070−52.3% | Reduced |
| Two Sigma Investments, LP | 28,214 | $66.0K | 0.00% | −21,239−42.9% | Reduced |
| Texas Capital Bank Wealth Management Services Inc | 23,750 | $55.6K | 0.00% | +23,750 | New |
| Geode Capital Management, LLC | 20,969 | $49.1K | 0.00% | +1,677+8.7% | Added |
| Captrust Financial Advisors | 18,295 | $42.8K | 0.00% | +18,295 | New |
| Northern Trust Corp | 17,400 | $40.7K | 0.00% | +17,400 | New |
| XTX Topco Ltd | 17,043 | $39.9K | 0.00% | +4,551+36.4% | Added |
| HRT Financial LP | 14,913 | $34.0K | 0.00% | +14,913 | New |
| Northwestern Mutual Wealth Management Co | 2,785 | $6.52K | 0.00% | −133−4.6% | Reduced |
| Tower Research Capital LLC (TRC) | 2,450 | $5.73K | 0.00% | −605−19.8% | Reduced |
| Jones Financial Companies LLLP | 1,228 | $2.87K | 0.00% | +1,228 | New |
| UBS Group AG | 777 | $1.82K | 0.00% | +762+5,080.0% | Added |
| BlackRock, Inc. | 84 | $197 | 0.00% | 00.0% | Unchanged |
| Rockefeller Capital Management L.P. | 83 | $194 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 37 | $87 | 0.00% | +1+2.8% | Added |
| Morgan Stanley | 34 | $80 | 0.00% | +34 | New |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −26,182−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −24,728−100.0% | Sold out |
| DRW Securities, LLC | 0 | $0 | 0.00% | −18,300−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −49−100.0% | Sold out |